✦ LIBER ✦

LDL-apheresis: results of longterm treatment and vascular outcome

✍ Scribed by Christiane Keller

Book ID: 118896562
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 812 KB
Volume: 86
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(91)90093-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of homozygous familial hyperch

Treatment of homozygous familial hypercholesterolemia by plasma exchange and LDL-apheresis

✍ Palcoux, J.B.; Meyer, M.; Jouanel, P.; Tridon, A.; Vanlieferinghen, P.; Carla, H 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 312 KB

1.P.200 Market reduction of LDL-apheresi

1.P.200 Market reduction of LDL-apheresis by treatment with LDL-apheresis and atorvastatin in a case of homozygous familial hypercholesterolemia (FH)

✍ Y. Mikami; Y. Homma; K. Tagata 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Treatment of acute occlusion of the reti

Treatment of acute occlusion of the retinal artery by LDL-apheresis

✍ Patrick M. Moriarty; Thomas J. Whittaker 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Assessment of cardiovascular outcomes by

Assessment of cardiovascular outcomes by holter monitoring during LDL apheresis in hypercholesterolemic patients: results of the French Multicenter Study

✍ F. Jan; A. Piolot; B. Jacotot; J. de Gennes; P. Tremisi; J.L. Schlienger; P. Mor 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 143 KB

LDL Apheresis in Clinical Practice: Long

LDL Apheresis in Clinical Practice: Long-Term Treatment of Severe Hyperlipidemia

✍ R. Bambauer; R. Schiel; R. Latza; J. Klinkmann; J.M. Schneidewind 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Use of Losartan in FH patients during tr

Use of Losartan in FH patients during treatment with DSC-LDL apheresis

✍ S. Pintus; P. Pintus; P. Maxia; S. Anedda 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 6 KB 👁 2 views

Angiotensin-converting-enzyme (ACE) inhibitors reduce morbidity and mortality in patients with chronic heart failure and systolic left-ventricular dysfunction, as well as in patients who have had a myocardial infarction . These drugs, in familial hypercholesterolemic (FH) patients treated with low-d